Vanguard Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Vanguard Group’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.39B	Sell	13,553,932 -11,520	-0.1%	-$5.1M	0.08%	241
2025 Q3	$6.19B	Buy	13,565,452 +268,313	+2%	+$109M	0.09%	198
2025 Q2	$4.34B	Buy	13,297,139 +240,534	+2%	+$66.6M	0.07%	277
2025 Q1	$3.53B	Buy	13,056,605 +323,206	+3%	+$83.1M	0.06%	297
2024 Q4	$3B	Buy	12,733,399 +98,303	+0.8%	+$25.9M	0.05%	348
2024 Q3	$3.48B	Buy	12,635,096 +127,318	+1%	+$33.1M	0.06%	310
2024 Q2	$3.04B	Buy	12,507,778 +513,517	+4%	+$81.1M	0.06%	322
2024 Q1	$1.79B	Buy	11,994,261 +50,366	+0.4%	+$8.4M	0.04%	480
2023 Q4	$2.29B	Buy	11,943,895 +287,064	+2%	+$48.9M	0.05%	381
2023 Q3	$2.06B	Buy	11,656,831 +30,608	+0.3%	+$5.84M	0.05%	381
2023 Q2	$2.21B	Buy	11,626,223 +18,056	+0.2%	+$3.58M	0.05%	385
2023 Q1	$2.33B	Buy	11,608,167 +101,051	+0.9%	+$21.2M	0.06%	353
2022 Q4	$2.73B	Buy	11,507,116 +453,808	+4%	+$96.8M	0.07%	295
2022 Q3	$2.21B	Buy	11,053,308 +10,870	+0.1%	+$2.07M	0.07%	324
2022 Q2	$1.61B	Buy	11,042,438 +213,294	+2%	+$30.3M	0.05%	432
2022 Q1	$1.77B	Buy	10,829,144 +126,373	+1%	+$19.3M	0.04%	463
2021 Q4	$1.81B	Buy	10,702,771 +88,189	+0.8%	+$16.4M	0.04%	465
2021 Q3	$2B	Buy	10,614,582 +116,888	+1%	+$21.9M	0.05%	421
2021 Q2	$1.78B	Sell	10,497,694 -88,127	-0.8%	-$12.9M	0.04%	462
2021 Q1	$1.49B	Buy	10,585,821 +59,397	+0.6%	+$8.94M	0.04%	492
2020 Q4	$1.37B	Sell	10,526,424 -5,782	-0.1%	-$772K	0.04%	481
2020 Q3	$1.53B	Sell	10,532,206 -368,978	-3%	-$52.4M	0.05%	391
2020 Q2	$1.61B	Buy	10,901,184 +355,379	+3%	+$47.9M	0.06%	355
2020 Q1	$1.15B	Buy	10,545,805 +258,333	+3%	+$29.8M	0.05%	401
2019 Q4	$1.18B	Buy	10,287,472 +124,601	+1%	+$12.4M	0.04%	492
2019 Q3	$817M	Buy	10,162,871 +846,185	+9%	+$66.9M	0.03%	586
2019 Q2	$676M	Buy	9,316,686 +657,595	+8%	+$50.5M	0.03%	666
2019 Q1	$809M	Buy	8,659,091 +439,757	+5%	+$36.8M	0.03%	576
2018 Q4	$599M	Buy	8,219,334 +614,081	+8%	+$47.2M	0.03%	629
2018 Q3	$666M	Buy	7,605,253 +66,740	+0.9%	+$6.71M	0.03%	667
2018 Q2	$742M	Buy	7,538,513 +95,107	+1%	+$9.43M	0.03%	600
2018 Q1	$887M	Buy	7,443,406 +179,492	+2%	+$23.1M	0.04%	534
2017 Q4	$923M	Buy	7,263,914 +771,016	+12%	+$96.9M	0.04%	520
2017 Q3	$763M	Buy	6,492,898 +73,390	+1%	+$6.26M	0.04%	559
2017 Q2	$512M	Buy	6,419,508 +759,295	+13%	+$48.5M	0.03%	692
2017 Q1	$290M	Buy	5,660,213 +200,890	+4%	+$9.28M	0.01%	980
2016 Q4	$204M	Buy	5,459,323 +41,374	+0.8%	+$1.73M	0.01%	1147
2016 Q3	$367M	Buy	5,417,949 +32,440	+0.6%	+$2.29M	0.02%	768
2016 Q2	$299M	Buy	5,385,509 +182,614	+4%	+$11.5M	0.02%	828
2016 Q1	$327M	Buy	5,202,895 +154,674	+3%	+$10.3M	0.02%	758
2015 Q4	$475M	Buy	5,048,221 +416,709	+9%	+$38.6M	0.03%	603
2015 Q3	$372M	Buy	4,631,512 +91,515	+2%	+$10.2M	0.03%	682
2015 Q2	$544M	Buy	4,539,997 +212,011	+5%	+$25.3M	0.04%	558
2015 Q1	$452M	Buy	4,327,986 +607,212	+16%	+$61.5M	0.03%	631
2014 Q4	$361M	Buy	3,720,774 +137,474	+4%	+$12.7M	0.03%	681
2014 Q3	$280M	Buy	3,583,300 +306,374	+9%	+$19.8M	0.02%	773
2014 Q2	$207M	Buy	3,276,926 +595,350	+22%	+$35.4M	0.02%	941
2014 Q1	$180M	Sell	2,681,576 -285,677	-10%	-$22.1M	0.02%	981
2013 Q4	$191M	Buy	2,967,253 +130,410	+5%	+$7.78M	0.02%	919
2013 Q3	$182M	Buy	2,836,843 +103,095	+4%	+$5.14M	0.02%	896
2013 Q2	$84.8M	Buy	+2,733,748	New	+$72.7M	0.01%	1279